Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Filings indexed 477 across all filing types
Latest filing 2024-01-16 Earnings Release
Country CH Switzerland
Listing SW ROSE

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base
Earnings Release Classification · 100% confidence The document is a press release dated January 16, 2024, detailing the company's financial performance for the fourth quarter of 2023 and the full year 2023. It explicitly mentions achieving revenue targets, growth percentages, and confirming an 'inflection point.' It also provides an outlook for 2024 and includes a table summarizing unaudited revenue figures for Q4 2023 vs Q4 2022 and FY 2023 vs FY 2022. This content structure—key highlights, performance metrics, and outlook—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim/Quarterly Report (IR), as it is presented as a 'Press release' announcing the results, rather than the full statutory filing. Q4 2023
2024-01-16 English
DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base
Earnings Release Classification · 100% confidence The document is a press release dated January 16, 2024, detailing the company's financial performance for the fourth quarter of 2023 and the full year 2023. It includes key metrics like revenue growth, active customer base, outlook confirmation, and operational updates (e-prescription rollout). This structure—announcing period results with key figures and outlook—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the detailed Interim Report (IR), but rather the initial announcement of the results. The presence of an 'Agenda' section also points to a scheduled results announcement. Q4 2023
2024-01-16 English
DocMorris erzielt signifikantes Umsatzplus im vierten Quartal 2023 und bestätigt Wendepunkt durch Zunahme des aktiven Kundenstamms
Earnings Release Classification · 100% confidence The document is a press release dated January 16, 2024, titled "DocMorris erzielt signifikantes Umsatzplus im vierten Quartal 2023 und bestätigt Wendepunkt durch Zunahme des aktiven Kundenstamms". It details financial performance for Q4 2023 and the full year 2023, including revenue figures, growth rates, and outlook confirmation. This content structure—announcing key financial highlights for a period (Q4/FY) immediately following the period close—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or a detailed Interim Report (IR), as it focuses on highlights and outlook confirmation rather than full statutory statements. It is also not a Call Transcript (CT) or an Investor Presentation (IP). The presence of an 'Agenda' section mentioning future 'Jahresergebnis 2023 und Ausblick 2024 (Conference Call/Webcast)' further supports that this is the initial release of the results. Q4 2023
2024-01-16 German
Menschenrechtsrichtlinien
Environmental & Social Information Classification · 98% confidence The document text is a detailed policy statement from DocMorris AG focusing heavily on human rights, ethical conduct, labor conditions, diversity, inclusion, and governance mechanisms, explicitly referencing frameworks like the UN Guiding Principles on Business and Human Rights ('Ruggie Framework') and the UN Global Compact. This content strongly aligns with reporting on Environmental, Social, and Governance (ESG) factors, which falls under the Environmental & Social Information category. The document is comprehensive and appears to be a standalone policy report rather than a brief announcement (ruling 2 does not apply). Therefore, the most appropriate classification is 'SR' (Environmental & Social Information).
2023-12-11 German
Human Rights Policy
Environmental & Social Information Classification · 98% confidence The document discusses DocMorris AG's commitment to human rights, ethical business practices, compliance with UN principles, and environmental responsibility. It explicitly mentions that more details on environmental work can be found in the "Sustainability Report 2022." This focus on Environmental, Social, and Governance (ESG) factors, particularly the detailed discussion of human rights and environmental impact mitigation, strongly aligns with the definition of an Environmental & Social Report (SR). Although it references a 'Sustainability Report 2022', the content provided is the report itself detailing these commitments, not merely an announcement of its publication.
2023-12-11 English
Terms of Reference of the Compensation and Nomination Committee
Governance Information Classification · 95% confidence The document is the 'Terms of Reference of the Compensation and Nomination Committee' for DocMorris AG. It outlines the governance structure, responsibilities, and operational procedures of the committee responsible for compensation and board nominations. This falls under the category of internal governance and board structure documentation, which is best classified as Governance Information (CGR).
2023-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.